ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R

Franck Morschhauser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.